Exenatide Once Weekly: A Review of Pharmacology and Treatment Considerations in Type 2 Diabetes.

导出 LinkOut

翻译打印收藏纠错

作者： Stephen,Brunton ^[1] ; Jaime A,Davidson ^[2]

作者单位： Primary Care Metabolic Group, Charlotte, North Carolina. Electronic address: sbrunton@pceconsortium.org. ^[1] The University of Texas Southwestern Medical Center, Touchstone Diabetes Center, Dallas, Texas. ^[2]

关键词 delayed-action preparations exenatide pharmacology type 2 diabetes

主题词血糖(Blood Glucose);心血管疾病(Cardiovascular Diseases);迟效制剂(Delayed-Action Preparations);糖尿病, 2型(Diabetes Mellitus, Type 2);用药计划表(Drug Administration Schedule);人类(Humans);降血糖药(Hypoglycemic Agents);肽类(Peptides);危险因素(Risk Factors);毒液类(Venoms)

DOI 10.1016/j.clinthera.2016.01.014

PMID 26926319

发布时间 2018-12-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览30

Clinical therapeutics

2016年38卷3期

582-94页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Exenatide Once Weekly: A Review of Pharmacology and Treatment Considerations in Type 2 Diabetes.

Clinical therapeutics

相似文献

Clinical therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Exenatide Once Weekly: A Review of Pharmacology and Treatment Considerations in Type 2 Diabetes.

Clinical therapeutics

相似文献

Clinical therapeutics

相关期刊

检索历史清除